GraniteShares 2x Long COIN Daily ETF vs Medtronic PLC — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $4.05, while Medtronic PLC trades at $89.95 (market cap $116.07B). The key difference: Medtronic PLC pays a 3.18% dividend while GraniteShares 2x Long COIN Daily ETF pays none, and Medtronic PLC is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.
| CONL | MDT | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $48.70 | $105.35 |
52-Week Low | $3.93 | $73.75 |
Market Cap | — | $116.07B |
Enterprise Value | — | $134.82B |
Dividend Yield | — | 3.18% |
Signals from Pluang's Aura AI — not financial advice
CONL, the GraniteShares 2x Long COIN Daily ETF, trades at $4.175, up 2.08% on the day, but remains in a pronounced bearish technical trend with all moving averages signaling sell. The ETF is designed to deliver twice the daily return of Coinbase stock (COIN), which has experienced significant volatility. Recent news highlights substantial losses, with CONL down 67% year-to-date as of June 2026, illustrating the high-risk nature of leveraged products.
The outlook is highly speculative and carries extreme risk due to the ETF's daily reset leverage, which can lead to rapid value erosion during volatile periods. Investment opportunity is limited to aggressive, short-term traders who can manage the volatility tax. The primary risk is the structural decay associated with daily rebalancing in a choppy market for the underlying asset.
Medtronic (MDT) trades at $89.41, up 2.58% on the day, reflecting positive momentum. The stock exhibits bullish technical signals with strong moving average support and a consensus analyst price target of $98.75. Fundamentally, the company reported revenue of $33.54B for 2025 with a net income margin of 13.2%, and has consistently beaten EPS estimates in recent quarters. Recent news highlights institutional acquisitions and positive developments in medical technology platforms.
The outlook for MDT is positive, driven by earnings beats, robust cash flow, and growth in cardiac and robotic surgery segments. Key opportunities include undervaluation relative to analyst targets and dividend stability. Risks involve rising debt levels and competitive pressures in the medtech sector. The stock presents a compelling case for growth-oriented income investors.
Trailing returns across standard periods
Latest headlines on both assets
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →